Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > Poking myself in the eye each day with TH

<< Previous

Bullboard Posts

Next >>

Comment by Momo25on Oct 15, 2021 9:06pm

224 Views

Post# 34012672

RE:RE:RE:RE:RE:Poking myself in the eye each day with TH

I have a question maybe someone has the answer. Why the board is not buying shares if they are so confident in their oncology/NASH programs? Market doesn't see their data. They do..
Quebec Government and even federal government are used to help Biotech companies when they are convinced there is an advantage to do so. Nothing!
For me all of that is noise over noise. Nothing tangible we can assess.

<< Previous

Bullboard Posts

Next >>

How one company is disrupting PoC testing